Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001193125-25-227202

PRESIDENT, CEO & INTERIM CFO sold 25,000 shares at $40.16 ($1,004,000)

  • PRESIDENT, CEO & INTERIM CFO acquired 25,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

MORTIMER IAN · PRESIDENT, CEO & INTERIM CFO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-10-01 Exercise or conversion : show line 1 in the form 10b5-1 +25,000 $7.69 $192,250 56,302 D
2025-10-01 Sale : show line 2 in the form 10b5-1 −25,000 $40.16 $1,004,000 31,302 D
Open-market sales · 25,000 sh · avg $40.16 · $1,004,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-10-01 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −25,000 0 D
Loading xslF345X05/ownership.xml…